文献速递甲状腺核医学

[11C]胆碱 PET/CT 检测功能亢进甲状旁腺的的诊断可靠性与临床影响

Diagnostic Reliability and Clinical Impact of [11C]Choline PET/CT for Detecting Hyperfunctioning Parathyroid Glands.
PubMed 文献 · J Nucl Med · 2025-11-03

本回顾性研究纳入174例生化证实的临床甲状旁腺功能亢进症(cHPT)患者,评估[11C]胆碱 PET/CT 术前定位功能亢进甲状旁腺的诊断效能。观察者间对检查阳性(Fleiss κ=0.636)和腺体定位(Fleiss κ=0.656)呈中等一致;基于患者的灵敏度92.2%、阳性预测值98.3%,基于病灶的灵敏度88.2%、阳性预测值96.8%;[11C]胆碱 PET/CT 引导手术后 cHPT 治愈率84.1%。作者认为诊断效能有前景,但中等观察者间一致性(尤其异位甲状旁腺定位准确性)提示需完善判读标准。

要点

  • 174例cHPT患者中,[11C]胆碱 PET/CT 基于患者的灵敏度92.2%、阳性预测值98.3%,基于病灶的灵敏度88.2%、阳性预测值96.8%。
  • 观察者间对检查阳性(Fleiss κ=0.636)和腺体定位(Fleiss κ=0.656)呈中等一致。
  • [11C]胆碱 PET/CT 引导手术后 cHPT 治愈率为84.1%(95% CI 73.5%-91.3%)。

核心结论

  • 研究结果支持[11C]胆碱 PET/CT 在 cHPT 患者中的诊断效能,但中等观察者间一致性(尤其与异位甲状旁腺定位准确性相关)提示需完善判读标准以改进该影像技术的使用。

研究设计与样本

  • 回顾性研究,纳入174例生化证实的 cHPT 患者,这些患者为术前定位甲状旁腺腺瘤接受了[11C]胆碱 PET/CT。
  • 收集每例患者的甲状旁腺激素水平、钙代谢、既往闪烁显像和超声结果以及可获得的组织病理学结果。
  • 三名审阅者评估腺瘤的存在和解剖定位,并评估观察者间一致性。
  • 诊断效能仅在因疑似功能亢进腺体接受手术切除或细针穿刺活检的患者中评估,以组织病理学结果为参考标准。

主要发现

  • 检查阳性方面达到中等观察者间一致性(Fleiss κ=0.636;95% CI 0.633-0.638),腺体定位方面亦为中等(Fleiss κ=0.656;95% CI 0.655-0.657)。
  • 基于患者的分析中,[11C]胆碱 PET/CT 的灵敏度为92.2%,阳性预测值为98.3%。
  • 基于病灶的分析中,灵敏度达88.2%,阳性预测值为96.8%。
  • [11C]胆碱 PET/CT 引导手术后 cHPT 治愈率为84.1%(95% CI 73.5%-91.3%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 中等观察者间一致性,尤其与异位甲状旁腺定位准确性相关,提示需完善判读标准以改进该影像技术的使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

[11C]choline PET/CT could become the preferred method for detecting hyperfunctioning parathyroid glands in patients with clinical hyperparathyroidism (cHPT), given its growing accessibility and superior diagnostic performance compared with conventional imaging. This study aimed to evaluate the robustness of [11C]choline PET/CT in identifying and localizing hyperfunctioning parathyroid glands in preoperative settings. Methods: This retrospective study included patients with biochemically proven cHPT who underwent [11C]choline PET/CT for preoperative localization of parathyroid adenomas. Parathyroid hormone levels, calcium metabolism, and previous scintigraphy and ultrasound results were collected for each patient, along with available histopathology results. Three reviewers evaluated the presence and anatomic localization of adenomas, and interobserver agreement was assessed. The diagnostic performance of [11C]choline PET/CT was assessed exclusively in patients who underwent surgical resection or fine-needle aspiration biopsy of the suspected hyperfunctioning glands, using histopathologic results as the reference standard. Results: This study included 174 patients. Moderate interobserver agreement was reached regarding examination positivity (Fleiss κ, 0.636; 95% CI, 0.633-0.638) and gland localization (Fleiss κ, 0.656; 95% CI, 0.655-0.657). In the patient-based analysis, [11C]choline PET/CT had a sensitivity of 92.2% and a positive predictive value of 98.3%; in the lesion-based analysis, the sensitivity reached 88.2%, with a positive predictive value of 96.8%. The cure rate of cHPT after [11C]choline PET/CT-guided surgery was 84.1% (95% CI, 73.5%-91.3%). Conclusion: Our findings support the diagnostic efficacy of [11C]choline PET/CT in patients with cHPT. Although the diagnostic performance is promising, the moderate interobserver agreement, particularly related to the accuracy of localizing ectopic parathyroid glands, calls for a refinement of interpretation criteria to improve the use of this imaging technique.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Lazar A, Matassa G, Hammami DW, et al. Diagnostic Reliability and Clinical Impact of [11C]Choline PET/CT for Detecting Hyperfunctioning Parathyroid Glands. J Nucl Med. 2025. PMID: 40998726. doi:10.2967/jnumed.125.270664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。